TNF and neoplasm: This strategy promoted CD3+ T-cell recruitment into tumors, amplified pro-inflammatory cytokine levels (e.g., IFN-γ, TNF-α), suppressed tumor growth and metastasis, and prolonged survival in preclinical models (75).